CRA-2059

Modify Date: 2025-08-26 19:17:26

CRA-2059 Structure
CRA-2059 structure
Common Name CRA-2059
CAS Number 256649-36-2 Molecular Weight 750.80
Density N/A Boiling Point N/A
Molecular Formula C34H46N12O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CRA-2059


CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].

 Names

Name CRA-2059

 CRA-2059 Biological Activity

Description CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].
Related Catalog
In Vitro Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1].
References

[1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.

[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.

 Chemical & Physical Properties

Molecular Formula C34H46N12O8
Molecular Weight 750.80
InChIKey SDKLWMXBZVGUHI-XPALAHHGSA-N
SMILES NC(N)=Nc1ccc(CNC(=O)N2CCN(C(=O)OC3COC4C(OC(=O)N5CCN(C(=O)NCc6ccc(N=C(N)N)cc6)CC5)COC34)CC2)cc1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

CRA-2059 suppliers

CRA-2059 price

Related Compounds: More...
1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]-3,6-dihydro-2H-pyridine-4-carboxamide
291538-79-9
CRA-026440 hydrochloride
847459-98-7
N-ethyl-4-[4-(3-fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]-6-methyl-N-(2-methylsulfanyl-4-propan-2-ylphenyl)pyrimidin-2-amine
226948-11-4
CRA-026440
847460-34-8
(2R)-2-[[2-[(6-carbamoyl-1H-benzimidazol-2-yl)methyl]-3-methylbenzimidazole-5-carbonyl]amino]-3-phosphonopropanoic acid
263870-19-5
[6-[[6-[4-[4-(5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl)oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-7-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6H-anthracen-2-yl]oxy]-3-hydroxy-2-methyloxan-4
120381-88-6
benzenesulfonic acid,1-[8-(2,4-dichlorophenyl)-2-methylquinolin-4-yl]-3,6-dihydro-2H-pyridine-4-carboxamide
694491-71-9
Ibrutinib (PCI-32765)
936563-96-1
2-(2-hydroxyphenyl)-1H-indole-5-carboximidamide
179748-10-8
Methyl 2-[(4-bromo-2-nitrophenyl)[(tert-butoxy)carbonyl]amino]-2-methylpropanoate
2680759-39-9
benzyl N-[1-(4-bromo-3-methylphenyl)-2-oxopiperidin-3-yl]carbamate
2680561-86-6
rac-(1R,4R,5R)-5-methyl-2-azabicyclo[2.2.1]heptane hydrochloride
2763584-72-9
2-(Aminomethyl)oxane-4-carboxylic acid hydrochloride
2758002-09-2
N-[(1R)-4-amino-2,3-dihydro-1H-inden-1-yl]acetamide
2137095-48-6
5-(1H-indol-3-yl)pentan-1-amine hydrochloride
2758002-22-9
Benzyl 4-(4-bromo-2-methylbenzoyl)piperazine-1-carboxylate
2680676-65-5
benzyl N-{5-[(4-bromo-3-methylphenyl)methyl]-1,3-thiazol-2-yl}carbamate
2680764-91-2
(2S)-3-(2-methylquinolin-4-yl)-2-(2,2,2-trifluoroacetamido)propanoic acid
2679948-63-9
(2S)-3-(2-methylquinolin-6-yl)-2-(2,2,2-trifluoroacetamido)propanoic acid
2679809-57-3